Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Results of General Meeting

13th Dec 2021 13:19

RNS Number : 4696V
Roquefort Investments PLC
13 December 2021
 

 

13 December 2021

 

 

Roquefort Investments plc

("Roquefort Investments" or the "Company")

 

Results of General Meeting

 

Roquefort Investments (LSE:ROQ), the London listed investment company established to acquire businesses focused on early-stage opportunities in the medical biotechnology sector, is pleased to announce that at the Company's General Meeting held earlier today, all resolutions proposed were duly passed.

 

The resolutions were put to shareholders via a poll, the results of which were as follows:

 

Resolution

Poll Results

For

Against

Abstain

Discretionary

Total

1

Shares

1,800,000

-

-

-

1,800,000

%

100%

-

-

-

100%

2

Shares

1,800,000

-

-

-

1,800,000

%

100%

-

-

-

100%

3

Shares

1,800,000

-

-

-

1,800,000

%

100%

-

-

-

100%

4

Shares

1,800,000

-

-

-

1,800,000

%

100%

-

-

-

100%

 

The total number of ordinary shares in issue on 9 December 2021, the deadline for casting votes by proxy in advance of the General Meeting, was 36,900,000 shares. 4.88% of voting capital was instructed in respect of the resolutions put to the Genaral Meeting.

 

 

Enquiries:

Roquefort Investments plc

Stephen West (Chairman)

+44 (0)20 3290 9339

 

Buchanan (Public Relations)

Ben Romney / Jamie Hooper

 

Optiva Securities Limited (Broker)

 

+44 (0)20 7466 5000

Christian Dennis

+44 (0)20 3411 1881

 

For further information on Roquefort Investments, please visit www.roquefortinvest.com and @roquefortinvest on Twitter.

 

LEI: ‎254900P4SISIWOR9RH34

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMBXBDDLBBDGBX

Related Shares:

Roquefort Thera
FTSE 100 Latest
Value8,154.94
Change-319.80